Non-Steroidal Anti-Inflammatory Drugs: An Overview of Cardiovascular Risks

by Mart A.F.J. van de Laar, Inger L. Meek, Harald E. Vonkeman
Published 2010-07-01

Cost-effectiveness of different treat-to-target strategies in rheumatoid arthritis: results from the DREAM registry

by Celine J. van de Laar, Martijn A. H. Oude Voshaar, Harald E. Vonkeman
Published 2019-04-01

Common patient-reported outcomes across ICHOM Standard Sets: the potential contribution of PROMIS®

by Caroline B. Terwee, Marloes Zuidgeest, Harald E. Vonkeman, David Cella, Lotte Haverman, Leo D. Roorda
Published 2021-09-01

Construct Validation of a Multidimensional Computerized Adaptive Test for Fatigue in Rheumatoid Arthritis.

by Stephanie Nikolaus, Christina Bode, Erik Taal, Harald E Vonkeman, Cees A W Glas, Mart A F J van de Laar
Published 2015-01-01

Further optimization of the reliability of the 28-joint disease activity score in patients with early rheumatoid arthritis.

by Liseth Siemons, Peter M ten Klooster, Harald E Vonkeman, Mart A F J van de Laar, Cees A W Glas
Published 2014-01-01

Development of a web-based patient decision aid for initiating disease modifying anti-rheumatic drugs using user-centred design methods

by Ingrid Nota, Constance H. C. Drossaert, Heleen C. Melissant, Erik Taal, Harald E. Vonkeman, Cees J. Haagsma, Mart A. F. J. van de Laar
Published 2017-04-01

Radiographic progression in early rheumatoid arthritis patients following initial combination versus step-up treat-to-target therapy in daily clinical practice: results from the DR...

by Laura M. M. Steunebrink, Letty G. A. Versteeg, Harald E. Vonkeman, Peter M. ten Klooster, Monique Hoekstra, Mart A. F. J. van de Laar
Published 2018-01-01

A systematic literature review of patient-reported outcome measures used in gout: an evaluation of their content and measurement properties

by Carly A. Janssen, Martijn A. H. Oude Voshaar, Peter M. ten Klooster, Tim L. Th. A. Jansen, Harald E. Vonkeman, Mart A. F. J. van de Laar
Published 2019-04-01

Calibration of the PROMIS physical function item bank in Dutch patients with rheumatoid arthritis.

by Martijn A H Oude Voshaar, Peter M ten Klooster, Cees A W Glas, Harald E Vonkeman, Erik Taal, Eswar Krishnan, Hein J Bernelot Moens, Maarten Boers, Caroline B Terwee, Piet L C M van Riel, Mart A F J van de Laar
Published 2014-01-01

Predictors of biologic-free disease control in patients with rheumatoid arthritis after stopping tumor necrosis factor inhibitor treatment

by Marjan Ghiti Moghadam, Femke B. G. Lamers-Karnebeek, Harald E. Vonkeman, Peter M. ten Klooster, Janneke Tekstra, Barbara van Schaeybroeck, Ruth Klaasen, Marieke van Onna, Hein J. Bernelot Moens, Henk Visser, Annemarie M. Schilder, Marc R. Kok, Robert B. M. Landewé, Piet L. C. M. van Riel, Mart A. F. J. van de Laar, Tim L. Jansen, on behalf of the Dutch National POET Collaboration
Published 2019-06-01

Multi-biomarker disease activity score as a predictor of disease relapse in patients with rheumatoid arthritis stopping TNF inhibitor treatment.

by Marjan Ghiti Moghadam, Femke B G Lamers-Karnebeek, Harald E Vonkeman, Peter M Ten Klooster, Janneke Tekstra, Annemarie M Schilder, Henk Visser, Eric H Sasso, David Chernoff, Willem F Lems, Dirk-Jan van Schaardenburg, Robert Landewe, Hein J Bernelot Moens, Timothy R D J Radstake, Piet L C M van Riel, Mart A F J van de Laar, Tim L Jansen, Dutch National POET Collaboration
Published 2018-01-01